Profile
APEN ABT BSX-PA SYK MDT BSX
Company Name Apollo Endosurgery, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Boston Scientific Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $579.72M $192.90B $175.45B $137.02B $131.98B $113.11B
Employees 0.20K 114.00K 45.00K 53.00K 95.00K 53.00K
CEO Charles S. McKhann Robert Ford Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha Michael F. Mahoney
Ratings
APEN ABT BSX-PA SYK MDT BSX
Quant Rating Score 3 2 3 3 1
Quant Rating Neutral Sell Neutral Neutral Strong Sell
Trading
APEN ABT BSX-PA SYK MDT BSX
Last Close $10 $130.03 $122.18 $360.13 $96.28 $101.76
High 52 $10 $140.22 $122.18 $403.53 $98.43 $108.14
Low 52 $10 $111.1 $122.18 $337.28 $79.61 $88.03
Price vs. 52 Week High 0 % -7.27 % 0 % -10.76 % -2.18 % -5.9 %
Price vs. 52 Week Low 0 % 17.04 % 0 % 6.77 % 20.94 % 15.6 %
Total Return
APEN ABT BSX-PA SYK MDT BSX
1 Month Return 0 % 1.16 % 0 % -3.82 % 0.52 % 2.54 %
3 Month Return 0 % -0.18 % 0 % -5.68 % 3.74 % -1.25 %
6 Month Return 0 % -3.54 % 0 % -8.65 % 11.38 % -4.04 %
9 Month Return 0 % -0.12 % 0 % -6.61 % 11.86 % -3.41 %
YTD Return 0 % 14.96 % 0 % 0.02 % 20.53 % 13.93 %
1 Year Return 0 % 11.01 % 0 % -7.35 % 13.27 % 12.65 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
APEN ABT BSX-PA SYK MDT BSX
Dividend Yield Percentage (TTM) - 2.17 % - 0.95 % 2.75 % -
Dividend Paid and Capex Coverage Ration (TTM) -11.39 % 1.46 % 5.44 % 2.47 % 1.29 % 5.44 %
Dividend Per Share (TTM) - 2.4 % - 3.4 % 2.83 % -
Payout Ratio (TTM) - 61.99 % - 39.56 % 75.84 % -
Growth
APEN ABT BSX-PA SYK MDT BSX
Asset Growth -16.19 % - 11.34 % 1.89 % 12.12 %
Gross Profit Growth 21.36 % 15.39 % 10.39 % 3.58 % 16.26 %
Revenue Growth 22.01 % 5.67 % 11.16 % 3.62 % 17.61 %
Revenue 3 Year -19.69 % 1.9 % 34.71 % 10.52 % 36.16 %
Revenue 5 Year -60.12 % 29.99 % 71.94 % 20.96 % 47.52 %
Revenue 10 Year -96.06 % 83.13 % 148.82 % 41.05 % 104.22 %
EBIT Growth -113.38 % 12.74 % 15.72 % 14.42 % 18.25 %
Net Income Growth -61.41 % -51.32 % 8.45 % 26.82 % 16.38 %
Net Income 3 Yeari Growth Per Share 23.04 % -5.58 % 36.22 % -3.39 % 72.31 %
Net Income 5 Yeari Growth Per Share 51.29 % 47.3 % 99.44 % 1.52 % -62.7 %
Net Income 10 Yeari Growth Per Share 95.03 % 24.34 % 122.27 % 48.51 % 1502.13 %
Operating Income Growth -44.91 % 17.92 % 11.14 % 15.77 % 20.82 %
Operating Cash Flow Growth (CFG) -116.29 % - 18.91 % 3.79 % 37.24 %
Operating 3 Year CFG 35.34 % -100 % 90.21 % 0.13 % 77.55 %
Operating 5 Year CFG 21.68 % -100 % 51.22 % 1.55 % 76.92 %
Operating 10 Year CFG 98.71 % -100 % 452.85 % 22.45 % 143.61 %
EPS Growth -19.51 % -51.24 % 8.02 % 31.05 % 16.61 %
EPS Diluted Growth -19.51 % -51.31 % 8.25 % 30.8 % 16.52 %
Book Value Per Share -60.4 % -100 % 8.31 % -1.16 % 11.25 %
Share Holder 3 Year Equity Growth Per Share 713.61 % -100 % 33.52 % -4.58 % 26.58 %
Share Holder 5 Year Equity Growth Per Share -78.21 % -100 % 68.35 % -1.29 % 48.35 %
Share Holder 10 Year Equity Growth Per Share -99.25 % -100 % 159.56 % -23.12 % 186.31 %
Dividend Per Share Growth - 6.54 % 5 % 1.11 % -100 %
Dividend 3 Year Growth Per Share - 25.03 % 20.89 % 10.78 % -100 %
Dividend 5 Year Growth Per Share - 63.45 % 46.18 % 29.33 % -
Dividend 10 Year Growth Per Share - 140.85 % 142.84 % 128.74 % -
Debt Growth 6.52 % - 5.23 % 13.95 % 17.44 %
Free Cash Flow Growth -113.75 % - 22.83 % -0.29 % 55.31 %
Updated On 31 Dec 2022 31 Dec 2025 31 Dec 2025 30 Apr 2025 31 Dec 2024
Profitability
APEN ABT BSX-PA SYK MDT BSX
Gross Profit Margin TTM 55.2 % 55.51 % 65.05 % 63.54 % 62.27 % 69.01 %
Return on Assets TTM -36.14 % 7.75 % 6.53 % 6.78 % 5.22 % 6.77 %
Return on Equity TTM -84.92 % 13.18 % 12.42 % 15.04 % 9.83 % 12.87 %
Return on Capital Employed TTM -39.35 % 11.56 % 8.97 % 14.07 % 7.63 % 10.62 %
Net Income Per EBT TTM 101.49 % 77.06 % 85.26 % 71.91 % 83.61 % 85.38 %
EBT Per Ebit TTM 141.09 % 105.19 % 97.5 % 80.09 % 91.74 % 85.24 %
EBIT Per Revenue TTM -36.2 % 18.16 % 17.33 % 22.44 % 17.87 % 19.78 %
Cash Flow To Debt Ratio TTM -54.78 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Receivables Turnover TTM 5.13 4.26 6.84 6.22 5.44 7.1
Payables Turnover TTM 4.64 4.78 6.75 - 5.08 6.21
Inventory Turnover TTM 1.89 2.94 2.32 1.72 2.13 2.13
Fixed Asset Turnover TTM 1023.79 % 385.33 % 451.15 % 647.99 % 485.18 % 468.06 %
Asset Turnover TTM 69.72 % 52.66 % 45.31 % 52.5 % 38.05 % 47.01 %
Operating Cash Flow Per Share TTM -0.77 5.22 3.12 13.19 5.55 3.12
Free Cash Flow Per Share TTM -0.84 3.96 2.55 11.2 4.06 2.55
Cash Per Share TTM 140.23 % 442.64 % 86.05 % 1071.9 % 649.63 % 85.99 %
Operating Cash Flow Sales Ratio TTM -40.68 % 20.57 % 23.91 % 20.08 % 20.46 % 23.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 108.78 % 75.85 % 81.6 % 84.91 % 73.19 % 81.6 %
Cash Flow Coverage Ratios TTM -54.78 % 70.47 % 38.4 % 33.95 % 24.44 % 38.4 %
Price To Free Cash Flows Ratio TTM -17.05 27.89 35.99 31.99 25.35 29.96
Price To Operating Cash Flows Ratio TTM -13 21.23 29.35 27.17 18.54 24.45
Price Cash Flow Ratio TTM -13 21.23 29.35 27.17 18.54 24.45
Income Statement (TTM)
APEN ABT BSX-PA SYK MDT BSX
Revenue $0.08B $44.33B $20.07B $25.12B $33.54B $20.07B
Gross Profit $0.04B $24.61B $13.85B $15.43B $21.91B $13.85B
Gross Profit Ratio 55.2% 55.51% 69.01% 61.44% 65.32% 69.01%
EBITDA $-0.03B $11.33B $3.73B $5.69B $9.22B $3.73B
Net Income $-0.04B $6.52B $2.89B $3.25B $4.66B $2.89B
EPS Diluted -0.98 3.72 1.94 8.4 3.61 1.94
Balance Sheet (MRQ)
APEN ABT BSX-PA SYK MDT BSX
Long Term Debt $0.04B $13.52B $9.37B $14.86B $25.64B $9.37B
Total Liabilities $0.08B $33.51B $17.39B $25.42B $43.42B $17.39B
Total Equity $0.03B $47.9B $22B $22.42B $48.26B $22B
Total Investments $0B $1.24B $0.56B $0.09B $6.75B $0.56B
Total Debt $0.06B $15.28B $11.15B $14.86B $28.52B $11.15B
Total Assets $0.11B $81.41B $39.4B $47.84B $91.68B $39.4B
Cash Flow Statement (TTM)
APEN ABT BSX-PA SYK MDT BSX
Net Income $-0.04B $13.4B $1.85B $3.25B $4.69B $1.85B
Inventory $-0.01B $-0.06B $-0.23B $0B $-0.29B $-0.23B
Dividends Paid $0B $-3.84B $0B $-1.28B $-3.59B $0B
Operating Cash Flow $-0.03B $8.56B $3.44B $5.04B $7.04B $3.44B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.76B $-1.86B $-0.79B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 112.35
ADGM Adagio Medical Holdings, Inc. 1.01
AEMD Aethlon Medical, Inc. 2.15
AFIB Acutus Medical, Inc. 0.0002
AHCO AdaptHealth Corp. 10.64
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 196.4
ALUR Allurion Technologies Inc. 1.13
AMIX Autonomix Medical, Inc. Common Stock 0.4103
ANIK Anika Therapeutics, Inc. 10.34
AORT Artivion, Inc. 40.375
APYX Apyx Medical Corporation 4.02
ARAY Accuray Incorporated 0.5547
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.905
AVNS Avanos Medical, Inc. 14.71
AVR Anteris Technologies Global Corp. Common Stock 5.77
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 34.52
ETFs With Exposure to APEN
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 151.53
IWC iShares Micro-Cap ETF 0.05 169.93
DFAS Dimensional U.S. Small Cap ETF 0 76.31
QQQS Invesco NASDAQ Future Gen 200 ETF 0.53 35.725
Unlock